Topics (27) View all

Skills (10)

Research experience

  • Jan 2010–
    present
    Research: Protein vaccine for Streptococcus pneumoniae
    St. Jude Children's Hospital · Infectious Diseases
    USA · Memphis
    Small scale production of antigens for preliminary testing. Scale up of fermentation and purification to multi-gram levels with concomitant development of processes suitable for deployment in a cGMP.
  • Feb 1993–
    present
    Research: St. Jude Children's Research Hospital
    St. Jude Children's Research Hospital · Department of Infectious Diseases
    USA · Memphis

Education

  • Sep 1988–
    Dec 1991
    University of Oxford
    Molecular biology/Biochemistry · D.Phil
    United Kingdom · Oxford
  • Sep 1984–
    Jun 1988
    The University of Warwick
    Biochemistry · BSc(Hons)
    United Kingdom · Warwick

Other

  • Languages
    English
    Little bit of French and German
  • Scientific Memberships
    ABRF, AAAS
  • Journal Referees
    BioTechniques
  • Other Interests
    Yeast fermentation for the production of optimum ester profiles and alcohol production (i.e. homebrewing beer)

Questions and Answers (34) View all

  • 5 What kind of protease inhibitor can I use in protein extraction without inhibition of the binding of his-tag on Ni2+ ion during purification?
    By Abdallah Hamieh · Université de Rouen
    Richard Heath · St. Jude Children's Research Hospital
    Anything that chelates metals can interfere with metal chelation affinity chromatography and are best avoided altogether, if possible. If you sure th... [more]
  • Answer added in Escherichia coli
    6 In E.coli, if every cell divides into half by binary fission, which cells exactly die?
    By Vishnu Kanth · University of Mysore
    Richard Heath · St. Jude Children's Research Hospital
    Have you never grown an overnight culture of E. coli, then taken an aliquot and diluted it into fresh media the next day and let them grow? If you ha... [more]
  • 5 What kind of protease inhibitor can I use in protein extraction without inhibition of the binding of his-tag on Ni2+ ion during purification?
    By Abdallah Hamieh · Université de Rouen
    Richard Heath · St. Jude Children's Research Hospital
    Basically you can use anything except EDTA. We use Roche EDTA-free tablets 
  • Answer added in Proteins
    5 Can anyone tell me the interpretation of the following protein names?
    By Xiaojing Sui · Chinese Academy of Sciences
    Richard Heath · St. Jude Children's Research Hospital
    In addition to what Yakov Koen said, you also need to know how the database searching software works. It is going to pull up the best match to the ob... [more]
  • Answer added in Spectrometry
    4 How am I going to prepare a solution (aqueous) that contains a known concentration of E. coli?
    By Ivan Bastasa · Mindanao State University - Iligan Institute of Technology
    Richard Heath · St. Jude Children's Research Hospital
    The optical density of the culture at 600 nm can be used as an indirect measure of the cell density at any given time. Just make sure you dilute the ... [more]

Publications (39) View all

  • Article: Inhibitors of fatty acid synthesis as antimicrobial chemotherapeutics.
    R J Heath, S W White, C O Rock
    [show abstract] [hide abstract]
    ABSTRACT: Fatty acid biosynthesis is an emerging target for the development of novel antibacterial chemotherapeutics. The dissociated bacterial system is substantially different from the large, multifunctional protein of mammals, and many possibilities exist for type-selective drugs. Several compounds, both synthetic and natural, target bacterial fatty acid synthesis. Three compounds target the FabI enoyl-ACP reductase step; isoniazid, a clinically used antituberculosis drug, triclosan, a widely used consumer antimicrobial, and diazaborines. In addition, cerulenin and thiolactomycin, two fungal products, inhibit the FabH, FabB and FabF condensation enzymes. Finally, the synthetic reaction intermediates BP1 and decynoyl- N-acetyl cysteamine inhibit the acetyl-CoA carboxylase and dehydratase isomerase steps, respectively. The mechanisms of action of these compounds, as well as the potential development of new drugs targeted against this pathway, are discussed.
    Applied Microbiology and Biotechnology 06/2002; 58(6):695-703. · 3.42 Impact Factor
  • Source
    Article: The licC gene of Streptococcus pneumoniae encodes a CTP:phosphocholine cytidylyltransferase.
    [show abstract] [hide abstract]
    ABSTRACT: The licC gene product of Streptococcus pneumoniae was expressed and characterized. LicC is a nucleoside triphosphate transferase family member and possesses CTP:phosphocholine cytidylyltransferase activity. Phosphoethanolamine is a poor substrate. The LicC protein plays a role in the biosynthesis of the phosphocholine-derivatized cell wall constituents that are critical for cell separation and pathogenesis.
    Journal of Bacteriology 09/2001; 183(16):4927-31. · 3.83 Impact Factor
  • Article: The FadR.DNA complex. Transcriptional control of fatty acid metabolism in Escherichia coli.
    Y Xu, R J Heath, Z Li, C O Rock, S W White
    [show abstract] [hide abstract]
    ABSTRACT: In Escherichia coli, the expression of fatty acid metabolic genes is controlled by the transcription factor, FadR. The affinity of FadR for DNA is controlled by long chain acyl-CoA molecules, which bind to the protein and modulate gene expression. The crystal structure of FadR reveals a two domain dimeric molecule where the N-terminal domains bind DNA, and the C-terminal domains bind acyl-CoA. The DNA binding domain has a winged-helix motif, and the C-terminal domain resembles the sensor domain of the Tet repressor. The FadR.DNA complex reveals how the protein interacts with DNA and specifically recognizes a palindromic sequence. Structural and functional similarities to the Tet repressor and the BmrR transcription factors suggest how the binding of the acyl-CoA effector molecule to the C-terminal domain may affect the DNA binding affinity of the N-terminal domain. We suggest that the binding of acyl-CoA disrupts a buried network of charged and polar residues in the C-terminal domain, and the resulting conformational change is transmitted to the N-terminal domain via a domain-spanning alpha-helix.
    Journal of Biological Chemistry 06/2001; 276(20):17373-9. · 4.77 Impact Factor
  • Article: Identification and analysis of the acyl carrier protein (ACP) docking site on beta-ketoacyl-ACP synthase III.
    [show abstract] [hide abstract]
    ABSTRACT: The molecular details that govern the specific interactions between acyl carrier protein (ACP) and the enzymes of fatty acid biosynthesis are unknown. We investigated the mechanism of ACP-protein interactions using a computational analysis to dock the NMR structure of ACP with the crystal structure of beta-ketoacyl-ACP synthase III (FabH) and experimentally tested the model by the biochemical analysis of FabH mutants. The activities of the mutants were assessed using both an ACP-dependent and an ACP-independent assay. The ACP interaction surface was defined by mutations that compromised FabH activity in the ACP-dependent assay but had no effect in the ACP-independent assay. ACP docked to a positively charged/hydrophobic patch adjacent to the active site tunnel on FabH, which included a conserved arginine (Arg-249) that was required for ACP docking. Kinetic analysis and direct binding studies between FabH and ACP confirmed the identification of Arg-249 as critical for FabH-ACP interaction. Our experiments reveal the significance of the positively charged/hydrophobic patch located adjacent to the active site cavities of the fatty acid biosynthesis enzymes and the high degree of sequence conservation in helix II of ACP across species.
    Journal of Biological Chemistry 04/2001; 276(11):8231-8. · 4.77 Impact Factor
  • Source
    Article: Inhibition of beta-ketoacyl-acyl carrier protein synthases by thiolactomycin and cerulenin. Structure and mechanism.
    [show abstract] [hide abstract]
    ABSTRACT: The beta-ketoacyl-acyl carrier protein (ACP) synthases are key regulators of type II fatty acid synthesis and are the targets for two natural products, thiolactomycin (TLM) and cerulenin. The high resolution structures of the FabB-TLM and FabB-cerulenin binary complexes were determined. TLM mimics malonyl-ACP in the FabB active site. It forms strong hydrogen bond interactions with the two catalytic histidines, and the unsaturated alkyl side chain interaction with a small hydrophobic pocket is stabilized by pi stacking interactions. Cerulenin binding mimics the condensation transition state. The subtle differences between the FabB-cerulenin and FabF-cerulenin (Moche, M., Schneider, G., Edwards, P., Dehesh, K., and Lindqvist, Y. (1999) J. Biol. Chem. 244, 6031-6034) structures explain the differences in the sensitivity of the two enzymes to the antibiotic and may reflect the distinct substrate specificities that differentiate the two enzymes. The FabB[H333N] protein was prepared to convert the FabB His-His-Cys active site triad into the FabH His-Asn-Cys configuration to test the importance of the two His residues in TLM and cerulenin binding. FabB[H333N] was significantly more resistant to both antibiotics than FabB and had an affinity for TLM an order of magnitude less than the wild-type enzyme, illustrating that the two-histidine active site architecture is critical to protein-antibiotic interaction. These data provide a structural framework for understanding antibiotic sensitivity within this group of enzymes.
    Journal of Biological Chemistry 04/2001; 276(9):6551-9. · 4.77 Impact Factor

About

I run a protein production facility for St Jude investigators. We utilize bacteria, insect cells and mammalian cells on scales of < 1 L to 120 L. Protein purification is performed with AKTAs either using tags or conventional chromatography. I also work on process development for projects moving to a cGMP.

Following (37) See all

Followers (22) See all